Kymera Signs a DNA-Encoded Library Based Drug Discovery Research Agreement with HitGen
Shots:
- HitGen to receive upfront and milestones from Kymera. The companies collaborated to identify small molecule leads against targets of interest to Kymera
- HitGen will leverage its platform technology based on DNA-encoded libraries (DEL) to discover compounds- that will be exclusively licensed to Kymera
- HitGen’s DELs include encoded syntheses for hundreds of millions of novels- diverse- drug-like small molecule and macrocycle compounds
Click here to read full press release/ article | Ref: HitGen | Image: LinkedIn
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
